BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8245717)

  • 1. Comparative binding of bile acids to serum lipoproteins and albumin.
    Ceryak S; Bouscarel B; Fromm H
    J Lipid Res; 1993 Oct; 34(10):1661-74. PubMed ID: 8245717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrahepatic deposition and cytotoxicity of lithocholic acid: studies in two hamster models of hepatic failure and in cultured human fibroblasts.
    Ceryak S; Bouscarel B; Malavolti M; Fromm H
    Hepatology; 1998 Feb; 27(2):546-56. PubMed ID: 9462656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of potentially toxic bile acids with human plasma proteins: binding of lithocholic (3 alpha-hydroxy-5 beta-cholan-24-oic) acid to lipoproteins and albumin.
    Malavolti M; Fromm H; Ceryak S; Shehan KL
    Lipids; 1989 Jul; 24(7):673-6. PubMed ID: 2779375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of low density lipoprotein receptor activity by bile acids: differential effects of chenodeoxycholic and ursodeoxycholic acids in the hamster.
    Malavolti M; Fromm H; Ceryak S; Roberts IM
    J Lipid Res; 1987 Nov; 28(11):1281-95. PubMed ID: 2828498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative aspects of the interaction of bile acids with human serum albumin.
    Roda A; Cappelleri G; Aldini R; Roda E; Barbara L
    J Lipid Res; 1982 Mar; 23(3):490-5. PubMed ID: 7077161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel binding site for bile acids on human serum albumin.
    Takikawa H; Sugiyama Y; Hanano M; Kurita M; Yoshida H; Sugimoto T
    Biochim Biophys Acta; 1987 Nov; 926(2):145-53. PubMed ID: 2444264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equilibration of labelled and endogenous bile acids in patients with liver cirrhosis after administration of (24-14C)cholic and chenodeoxycholic acids.
    Hedenborg G; Jönsson G; Wisén O; Norman A
    Scand J Clin Lab Invest; 1991 Apr; 51(2):197-208. PubMed ID: 2042024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes.
    Bouscarel B; Fromm H; Ceryak S; Cassidy MM
    Biochem J; 1991 Dec; 280 ( Pt 3)(Pt 3):589-98. PubMed ID: 1764022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of bile acids by glutathione S-transferases from rat liver.
    Takikawa H; Sugiyama Y; Kaplowitz N
    J Lipid Res; 1986 Sep; 27(9):955-66. PubMed ID: 3783048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids regulate hepatic low density lipoprotein receptor activity in the hamster by altering cholesterol flux across the liver.
    Spady DK; Stange EF; Bilhartz LE; Dietschy JM
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1916-20. PubMed ID: 3456612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in serum bile acids in normal human subjects following the adoption of a low-fat diet.
    Martucci CP; Miller DG; Levine B; Tint GS; Fishman J
    Ann N Y Acad Sci; 1995 Sep; 768():331-3. PubMed ID: 8526380
    [No Abstract]   [Full Text] [Related]  

  • 12. The regulation of bile acid synthesis in cultured hamster hepatocytes.
    Hoang VQ; Botham KM; Pearce NJ; Suckling KE
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):284S. PubMed ID: 8224434
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipolysis-induced partitioning of free fatty acids to lipoproteins: effect on the biological properties of free fatty acids.
    Chung BH; Tallis GA; Cho BH; Segrest JP; Henkin Y
    J Lipid Res; 1995 Sep; 36(9):1956-70. PubMed ID: 8558084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal venous bile acids in cholesterol gallstone disease: effect of treatment with chenodeoxycholic and cholic acids.
    Einarsson K; Ahlberg J; Angelin B; Björkhem I; Ewerth S
    Hepatology; 1985; 5(4):661-5. PubMed ID: 4018738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for distinct precursor pools for biliary cholesterol and primary bile acids in cebus and cynomolgus monkeys.
    Stephan ZF; Hayes KC
    Lipids; 1985 Jun; 20(6):343-9. PubMed ID: 4021742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of serum bile acids in patients with liver cirrhosis and hyperbilirubinaemia.
    Hedenborg G; Norman A; Wisén O
    Scand J Clin Lab Invest; 1988 Dec; 48(8):817-24. PubMed ID: 2853444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid transport by serum lipoproteins in patients with extrahepatic cholestasis.
    Hedenborg G; Norlander A; Norman A; Svensson A
    Scand J Clin Lab Invest; 1986 Dec; 46(8):745-50. PubMed ID: 3797986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting and postprandial serum bile acid concentration with special reference to variations in the conjugate profile.
    Hedenborg G; Norman A
    Scand J Clin Lab Invest; 1985 Apr; 45(2):151-6. PubMed ID: 4001824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of bile acid glucuronides in hepatobiliary diseases.
    Takikawa H; Otsuka H; Beppu T; Seyama Y; Yamakawa T
    Digestion; 1983; 27(4):189-95. PubMed ID: 6653918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of individual non-sulfated bile acids and sulfated lithocholic acid in serum by mass fragmentography.
    Beppu T; Seyama Y; Kasama T; Yamakawa T
    J Biochem; 1981 Jun; 89(6):1963-73. PubMed ID: 7287668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.